The cash flow of Textron Inc. over the past 10 years
Chart Textron Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Textron Inc.'s operating cash flow was $1.31B and its capital expenditures $383M, leaving free cash flow of $929M. Free cash flow was above zero in all 10 years shown. It ranged from $451M in fiscal 2020 to $1.22B in fiscal 2021. Capital expenditures were highest in fiscal 2016, at $446M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Jan 3, 2026 | $1.31B | $383M | $929M |
| 2024ended Dec 28, 2024 | $1.01B | $364M | $650M |
| 2023ended Dec 30, 2023 | $1.27B | $402M | $864M |
| 2022ended Dec 31, 2022 | $1.49B | $354M | $1.13B |
| 2021ended Jan 1, 2022 | $1.6B | $375M | $1.22B |
| 2020ended Jan 2, 2021 | $768M | $317M | $451M |
| 2019ended Jan 4, 2020 | $1.01B | $339M | $675M |
| 2018ended Dec 29, 2018 | $1.11B | $369M | $738M |
| 2017ended Dec 30, 2017 | $936M | $423M | $513M |
| 2016ended Dec 31, 2016 | $925M | $446M | $479M |
Fiscal years as Textron Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Textron Inc.
- The revenue of Textron Inc.
- The profitability of Textron Inc.
- The debt of Textron Inc.
- The dividends of Textron Inc.
- All of Textron Inc.'s financials, charted
Companies of a similar size
- LSCCLATTICE SEMICONDUCTOR CORP
- BBIOBridgeBio Pharma, Inc.
- MTZMASTEC INC
- ARCCAres Capital Corp
- BJBJ’S WHOLESALE CLUB HOLDINGS, INC.
Not investment advice. This page shows what Textron Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.